2-Propenoic acid, 2-cyano-, dodecyl ester | 74784-57-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-Propenoic acid, 2-cyano-, dodecyl ester
• 英文别名: dodecyl 2-cyanoprop-2-enoate
• CAS: 74784-57-9
• 化学式: C₁₆H₂₇NO₂
• 分子量: 265.39
• InChiKey: LFJLAWZRNOKTDN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  19
• 可旋转键数：
  13
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  50.1
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• RAPIDLY CURING CYANOACRYLATES AS ADHESIVES
  申请人：Swords Noeleen

  公开号：US20100029978A1

  公开（公告）日：2010-02-04

  The present invention relates to a polymerizable adhesive composition which comprises, at least as one constituent, a cyanacrylate component and which requires a comparitively short time for curing when used on surfaces. The present invention therefore also includes a method for the production of the cyanacrylate component described above, and the cyanacrylate component as such.

  本发明涉及一种聚合粘合剂组成物，至少包括一种氰基丙烯酸酯组分，并在表面使用时需要相对较短的固化时间。因此，本发明还包括上述氰基丙烯酸酯组分的制备方法以及氰基丙烯酸酯组分本身。
• MEDICAL ADHESIVE COMPOSITIONS
  申请人：Liu Hongbo

  公开号：US20110230561A1

  公开（公告）日：2011-09-22

  A medical adhesive composition comprising, based upon the total weight of the composition, from about 50 wt. % to about 99.9 wt. % of one or more α-cyanoacrylate monomers and from about 0.1 wt. % to about 5 wt. % of one or more non-steroidal anti-inflammatory drugs (NSAIDs). Suitable NSAIDs include ibuprofen and acetaminophen. The resulting compositions provide enhances fibroblast proliferation and reduced cytotoxicity compared to compositions that do not contain NSAID.

  一种医用粘合剂组合物，包括以组合物的总重量为基础，约50重量％至约99.9重量％的一种或多种α-氰基丙烯酸酯单体和约0.1重量％至约5重量％的一种或多种非甾体抗炎药（NSAIDs）。适用的NSAIDs包括布洛芬和对乙酰氨基酚。与不含NSAID的组合物相比，所得到的组合物提供了增强成纤维细胞增殖和减少细胞毒性的效果。
• CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL
  申请人：Salamone Beal Ann

  公开号：US20070041935A1

  公开（公告）日：2007-02-22

  Liquid hemostatic coating materials comprise a cyanoacrylate monomer and a solvent system comprising a volatile, non-reactive liquid that is non-stinging and non-irritating to a user. The material forms a coating or bandage in the form of a film that when applied and adhered to a surface or to the skin of a user inhibits the application surface from adhering to another surface.

  液态止血涂层材料包括氰基丙烯酸酯单体和溶剂体系，其中溶剂体系包括一种挥发性、非反应性液体，对用户无刺激性和无刺激性。该材料形成一种涂层或绷带形式的薄膜，当应用并粘附到表面或用户的皮肤上时，抑制应用表面与另一表面粘附。
• Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone and 2,4,4'-trichloro-2' -hydroxydiphenyl ether
  申请人：Bordoloi K. Binoy

  公开号：US20060093572A1

  公开（公告）日：2006-05-04

  A polymerizable antimicrobial formulation for forming a wound closure adhesive comprising cyanoacrylate monomer, diiodomethyl-p-tolylsulfone and a halogenated hydroxyl diphenyl ether; and a method for closing the approximated edges of a wound with a polymeric film that substantially inhibits the growth of microorganisms, where the polymeric film is formed by use of the polymerizable antimicrobial formulation.

  一种可聚合的抗菌配方，用于形成创口闭合胶粘剂，包括氰基丙烯酸酯单体、二碘甲基对甲苯磺酰和卤代羟基二苯醚；以及一种使用聚合抗菌配方形成聚合膜的方法，该聚合膜能够有效抑制微生物的生长，用于关闭创口的近似边缘。
• Absorbable alpha-cyanoacrylate compositions
  申请人：Liu Hongbo

  公开号：US20060216266A1

  公开（公告）日：2006-09-28

  A monomer composition comprising at least one polymerizable alkyl ester α-cyanoacrylate monomer. Specifically, the α-cyanoacrylate monomer is an alkyl ester α-cyanoacrylate monomer of the general formula having a spacer R1: wherein n is from 2 to 12; R3 and R4 are each an alkyl group or a hydrogen, and at least one of R3 or R4 is an alkyl group (e.g. linear or branched, or cyclic) having from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 and 13 carbon atoms; R2 is an alkyl group (e.g. linear or branched, or cyclic) having from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 and 13 carbon atoms; and the combined number of carbon atoms (N) in the spacer R1 is at least n+1.

  一种单体组合物，包括至少一种可聚合的烷基酯基α-氰基丙烯酸酯单体。具体地，α-氰基丙烯酸酯单体是一种具有间隔基R1的烷基酯基α-氰基丙烯酸酯单体，其中n为2至12；R3和R4分别是烷基或氢，且R3或R4中至少有一个是具有1、2、3、4、5、6、7、8、9、10、11、12和13个碳原子的烷基（例如线性或支链或环状）；R2是具有1、2、3、4、5、6、7、8、9、10、11、12和13个碳原子的烷基（例如线性或支链或环状）；并且间隔基R1中碳原子的总数（N）至少为n+1。